Exact Mass: 516.1402

(2S,3R,4S,5R,6S)-6-[(2S,3R,4R,5R,6S)-2-[(2S,3R,4R,5R,6S)-2-carboxy-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxy-6-methyloxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C18H28O17 (516.1326)

Carindacillin sodium

C26H25N2O6S. Na (516.1331)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01283

b-D-Glucuronopyranosyl-(1->3)-a-D-galacturonopyranosyl-(1->2)-L-rhamnose

C18H28O17 (516.1326)

b-D-Glucuronopyranosyl-(1->3)-a-D-galacturonopyranosyl-(1->2)-L-rhamnose is found in coffee and coffee products. b-D-Glucuronopyranosyl-(1->3)-a-D-galacturonopyranosyl-(1->2)-L-rhamnose is isolated from the partial acid hydrolsates of the mucilage of Abelmoschus manihot (aibika) and Okra mucilage R in fruits and roots of Abelmoschus esculentus. Isolated from the partial acid hydrolsates of the mucilage of Abelmoschus manihot (aibika) and Okra mucilage R in fruits and roots of Abelmoschus esculentus. b-D-Glucuronopyranosyl-(1->3)-a-D-galacturonopyranosyl-(1->2)-L-rhamnose is found in many foods, some of which are coffee and coffee products, fruits, fats and oils, and green vegetables.

Gericudranin A

C29H24O9 (516.142)

Racemosic acid

C22H28O14 (516.1479)

Thelephantin A

C29H24O9 (516.142)

2)-6-deoxy-L-mannose

C18H28O17 (516.1326)

Coumarin + 1O + 1MeO, O-Hex-Hex

C22H28O14 (516.1479)

Annotation level-3

gnetoflavanol C

C29H24O9 (516.142)

7-(O6-beta-D-glucopyranosyl-beta-D-glucopyranosyloxy)-6-methoxy-coumarin|7-(O6-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy)-6-methoxy-cumarin|scopoletin beta-gentiobioside

C22H28O14 (516.1479)

Ustilaginoidin E

C29H24O9 (516.142)

Benastatin H

C29H24O9 (516.142)

Gericudranins A

C29H24O9 (516.142)

4-O-cinnamoyl-cleomiscosin A

C29H24O9 (516.142)

gnetoflavanol D

C29H24O9 (516.142)

4-O-(3-O-alpha-D-glucopyranosyl)caffeoylquinic acid

C22H28O14 (516.1479)

4-O-(4-O-alpha-D-glucopyranosyl)caffeoylquinic acid

C22H28O14 (516.1479)

penilumamide

C22H24N6O7S (516.1427)

beta-D-GpA1 -> 3 D-GalpA1 -> 2L-Rha

C18H28O17 (516.1326)

O-(D-Galaktopyranosyluronsaeure)-(1->4)-O-(D-galactopyranosyluronsaeure)-(1->2)-L-rhamnose|O-alpha-4-D-Galacturonosyl-(1->4)-O-alpha-D-galacturonosyl-(1->2)-O-L-rhamnose

C18H28O17 (516.1326)

Rha1GalA2

C18H28O17 (516.1326)

5-hydroxy-2-methylchromone-7-O-rutinoside

C22H28O14 (516.1479)

O-(beta-D-Glucopyranosyluronsaeure)-(1->3)-O-(alpha-D-galactopyranosyluronsaeure)-(1->3)-L-rhamnose

C18H28O17 (516.1326)

Me ester-Viburnolide C

C22H28O14 (516.1479)

5-O-(3-O-Glucosylcaffeoyl)quinic acid

C22H28O14 (516.1479)

Cys Cys Glu Tyr

C20H28N4O8S2 (516.1348)

Cys Cys Tyr Glu

C20H28N4O8S2 (516.1348)

Cys Glu Cys Tyr

C20H28N4O8S2 (516.1348)

Cys Glu Tyr Cys

C20H28N4O8S2 (516.1348)

Cys Tyr Cys Glu

C20H28N4O8S2 (516.1348)

Cys Tyr Glu Cys

C20H28N4O8S2 (516.1348)

Glu Cys Cys Tyr

C20H28N4O8S2 (516.1348)

Glu Cys Tyr Cys

C20H28N4O8S2 (516.1348)

Glu Tyr Cys Cys

C20H28N4O8S2 (516.1348)

Tyr Cys Cys Glu

C20H28N4O8S2 (516.1348)

Tyr Cys Glu Cys

C20H28N4O8S2 (516.1348)

Tyr Glu Cys Cys

C20H28N4O8S2 (516.1348)

Ketoconazole Metabolite (1-Piperazinecarboxaldehyde, 4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-

C25H26Cl2N4O4 (516.1331)

b-D-Glucuronopyranosyl-(1->3)-a-D-galacturonopyranosyl-(1->2)-L-rhamnose

C18H28O17 (516.1326)

[1,1-Biphenyl]-4-carboxylic acid [3aR-[3aa,4a(E),5b,6aa]]-4-[4-(3-chlorophenoxy)-3-oxo-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester

C30H25ClO6 (516.134)

Vat Green 1

C36H20O4 (516.1362)

Tetraphenyllead

C24H20Pb (516.1331)

benzene-1,3-dicarboxylic acid,furan-2,5-dione,hexanedioic acid,2-(2-hydroxyethoxy)ethanol

C22H28O14 (516.1479)

SRT 2104

C26H24N6O2S2 (516.1402)

SRT 2104 is a first-in-class, highly selective and brain-permeable activator of the NAD+ dependent deacetylase Sirt1, increases Sirt1 protein, but shows no effect on Sirt1 mRNA. Used in the research of diabetes mellitus and Huntington’s disease[1][2][3].

(S,S)-1,2-BIS[(TERT-BUTYL)METHYLPHOSPHINO]ETHANE[ETA-(2,5-NORBORNADIENE)]RHODIUM(I) TETRAFLUOROBORATE

C19H36BF4P2Rh (516.1376)

5-Oxa-1-azabicyclo 4.2.0 oct-2-ene-2-carboxylic acid, 3-(chloromethyl)-7- (4-Met

C29H25ClN2O5 (516.1452)

CARBENICILLIN INDANYL SODIUM

C26H25N2NaO6S (516.1331)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

7-[4-(4-Acetamidophenyl)sulfonyl-1-piperazinyl]-1-ethyl-6-fluoro-4-oxo-3-quinolinecarboxylic acid

C24H25FN4O6S (516.1479)

beta-D-glucuronosyl-(1->3)-alpha-D-galacturonosyl-(1->2)-L-rhamnose

C18H28O17 (516.1326)

7-(3-Amino-3-carboxypropyl)wyosine 5-monophosphate

C18H25N6O10P (516.137)

A ribonucleoside 5-monophosphate that is wyosine 5-monophosphate substituted at position 7 by a 3-amino-3-carboxypropyl group.

(12S,13R)-12-acetyl-9,13,19-trihydroxy-5,10,21-trimethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1,3,5,8,10,15,18(23),19,21-nonaene-7,17-dione

C29H24O9 (516.142)

4-[2-(hydroxymethyl)-5-methoxy-9-oxo-2h,3h-[1,4]dioxino[2,3-h]chromen-3-yl]-2-methoxyphenyl 3-phenylprop-2-enoate

C29H24O9 (516.142)

(2s,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one

C29H24O9 (516.142)

4-(2,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-11-(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O9 (516.142)

(2s,3r,4r,5r,6s)-3-{[(2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-4,5-dihydroxy-6-{[(2r,3s,4r,5r)-3,4,5-trihydroxy-1-oxohexan-2-yl]oxy}oxane-2-carboxylic acid

C18H28O17 (516.1326)

beta-d-glucopyranuronosyl-(1→3)-alpha-d-galactopyranuronosyl-(1→2)-l-rhamnose

C18H28O17 (516.1326)

{"Ingredient_id": "HBIN018079","Ingredient_name": "beta-d-glucopyranuronosyl-(1\u21923)-alpha-d-galactopyranuronosyl-(1\u21922)-l-rhamnose","Alias": "NA","Ingredient_formula": "C18H28O17","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "4","PubChem_id": "NA","DrugBank_id": "NA"}

5,6-dihydroxy-2-methyl-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}chromen-4-one

C22H28O14 (516.1479)

7-{[(2r,3s,4s,5s,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3s,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-methoxychromen-2-one

C22H28O14 (516.1479)

thelephantins

C29H24O9 (516.142)

7,9,10-trihydroxy-3-methyl-8-(1,3,9-trihydroxy-6-methyl-8-oxo-6,7-dihydro-5h-anthracen-2-yl)-3h,4h-naphtho[2,3-c]pyran-1-one

C29H24O9 (516.142)

2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-4-methanesulfinyl-n-[2-(methoxycarbonyl)phenyl]butanimidic acid

C22H24N6O7S (516.1427)

(2z)-3-[5,6,11,13-tetrahydroxy-4-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,8-dioxatricyclo[7.4.0.0²,⁷]trideca-1(13),9,11-trien-12-yl]but-2-enoic acid

C22H28O14 (516.1479)

(2e)-3-[(2s,4r,5s,6r,7s)-5,6,11,13-tetrahydroxy-4-(hydroxymethyl)-10-[(2r,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,8-dioxatricyclo[7.4.0.0²,⁷]trideca-1(9),10,12-trien-12-yl]but-2-enoic acid

C22H28O14 (516.1479)

(2s)-2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-4-methanesulfinyl-n-[2-(methoxycarbonyl)phenyl]butanimidic acid

C22H24N6O7S (516.1427)

3-[(6-carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-4,5-dihydroxy-6-[(3,4,5-trihydroxy-1-oxohexan-2-yl)oxy]oxane-2-carboxylic acid

C18H28O17 (516.1326)

7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-methoxychromen-2-one

C22H28O14 (516.1479)

7-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-methoxychromen-2-one

C22H28O14 (516.1479)

(4s,5s,11r,12s)-4-(3,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-11-(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O9 (516.142)

methyl (3r)-3-[(3s,3ar,6s,6ar)-3,6-dihydroxy-2-oxo-3a-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dihydro-5h-furo[3,2-b]furan-3-yl]-3-(4-hydroxyphenyl)propanoate

C22H28O14 (516.1479)

(4r,5r,11r,12s)-4-(2,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-11-(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O9 (516.142)

2-{[3,4-dihydroxy-6-(methoxycarbonyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-[5-(4-hydroxy-2-oxopyrimidin-1-yl)-4-(c-hydroxycarbonimidoyloxy)-3-methoxyoxolan-2-yl]ethanimidic acid

C19H24N4O13 (516.134)

4-[(2r,3r)-2-(hydroxymethyl)-5-methoxy-9-oxo-2h,3h-[1,4]dioxino[2,3-h]chromen-3-yl]-2-methoxyphenyl (2e)-3-phenylprop-2-enoate

C29H24O9 (516.142)

(11r,12s)-4-(3,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-11-(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O9 (516.142)

(11r,12s)-4-(2,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-11-(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O9 (516.142)

7,9,10-trihydroxy-3-methyl-6-(2,4,10-trihydroxy-7-methyl-5-oxo-7,8-dihydro-6h-anthracen-1-yl)-3h,4h-naphtho[2,3-c]pyran-1-one

C29H24O9 (516.142)

4-(3,4-dihydroxyphenyl)-5-(3,5-dihydroxyphenyl)-11-(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O9 (516.142)

5,6-dihydroxy-2-methyl-7-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]chromen-4-one

C22H28O14 (516.1479)

methyl 3-(3,6-dihydroxy-2-oxo-3a-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dihydro-5h-furo[3,2-b]furan-3-yl)-3-(4-hydroxyphenyl)propanoate

C22H28O14 (516.1479)